From left to right: Milica Radisic, Rick Lu and Claudia dos Santos March 27, 2024 By Betty Zou University of Toronto researchers have created a unique heart-on-a-chip model that is helping untangle the causes of COVID-19-induced heart inflammation and uncover...
From left to right: Robert Kozak, Sharmistha Mishra and Darrell Tan March 7, 2024 By Betty Zou A new University of Toronto study has found that mpox virus DNA can be found in different parts of the body for up to four weeks after symptom onset. The study, led by...
Samantha Ismail led a study looking for antibodies against SARS-CoV-2 in human milk. January 23, 2024 By Betty Zou The COVID-19 pandemic was an especially harrowing time for pregnant people and new parents. The uncertainties about how the new coronavirus could affect...
January 3, 2024 By Selah Katona University of Toronto engineering researchers have developed a new method to visualize tiny 3D structures made of human DNA that could advance research on a range of applications — including a potential vaccine for certain types of...
Teresa Bennett (left) and Reina Bendayan (Photo credit: Steve Southon) December 18, 2023 By Eileen Hoftyzer Advances in treatment for human immunodeficiency virus (HIV) have not only helped to extend the lives of people living with the virus but can also prevent...
From left to right: Institute of Biomedical Engineering PhD trainee Jingan Chen, Leslie Dan Faculty of Pharmacy assistant professor Bowen Li, Li lab postdoctoral researcher Yue Xu December 11, 2023 By Kate Richards A team of researchers based at the University of...
Subha Dahal (left) and Alice Zhabokritsky December 1, 2023 By Betty Zou Over four decades after the start of the AIDS epidemic, researchers in the Emerging and Pandemic Infections Consortium are reshaping approaches to target the human immunodeficiency virus (HIV)...
A new study from a team of EPIC members has uncovered the biological reasons underlying sex differences in COVID-19 outcomes and is offering a promising new strategy to prevent illness. Early on during the pandemic, clinicians quickly noticed that males were more likely than females to be hospitalized or admitted to the ICU or to die from COVID-19 despite having similar infection rates. This pattern held true across all age groups and in countries around the world. The research, conducted in mice and published in the journal iScience, points to the ACE2 protein as a key contributor to differences in COVID-19 outcomes between males and females.
A new study from University of Toronto researchers is shedding more light on how the community of microbes in our gut contribute to a well-functioning immune system and defend against harmful pathogens.
It seems appropriate that the Toronto offices for Kamran Khan’s BlueDot, which uses artificial intelligence to flag potential infectious disease outbreaks around the world, are located at the edge of Lake Ontario. Similar to a lighthouse, BlueDot signals when there’s danger ahead. BlueDot’s intelligence platform combines a computer’s ability to understand human language, known as natural language understanding (NLU), and machine learning, a form of AI that imitates humans’ ability to learn and gradually become more accurate. The platform sorts through massive volumes of online information— ranging from news reports, social media sites, government websites, and more — from around the globe, in over 130 languages, every 15 minutes of every day.
Related page →
Link to resource →
Contact us CTA →